Acute myocardial infarction with sumatriptan: A case report and review of the literature

Headache

Volumn 49, Issue 5, 2009, Pages 762-764

  Chalaupka, Flavio Devetag ^a,b  

^a S Maria Del Prato Neurology ^*  (Italy)

^b S Maria del Prato Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERGOTAMINE; HEPARIN; INDOMETACIN; SUMATRIPTAN;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; LOW DRUG DOSE; MIGRAINE; MIGRAINE WITHOUT AURA; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ASPIRIN; CORONARY VASOSPASM; CORONARY VESSELS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEPARIN; HUMANS; HYPERTENSION; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; MYOCARDIAL INFARCTION; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 65449133208     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01409.x     Document Type: Article

References (14)

1. Nilsson T, Longmore J, Shaw D, Olesen IJ, Edvinsson L. Contractile 5-HT1B receptors in human cerebral arteries: Pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol. 1999 128 : 1133 1140. (Pubitemid 29229863)
2. Edvinsson L, Uddman E, Wackenfors A, Davenport A, Longmore J, Malmsjö M. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: Relationship to clinical effect. Clin Sci (Lond). 2005 109 : 335 342. (Pubitemid 41337139)
3. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004 62 : 563 568. (Pubitemid 38252796)
4. Fulton JA, Kahn J, Nelson LS, Hoffman RS. Renal infarction during the use of rizatriptan and zolmitriptan: Two case reports. Clin Toxicol (Phila). 2006 44 : 177 180. (Pubitemid 44112951)
5. Tietjen EG. Migraine and ischaemic heart disease and stroke: Potential mechanisms and treatment implications. Cephalalgia. 2007 27 : 981 987. (Pubitemid 47125362)
6. Melek IM, Seyfeli E, Duru M, Duman T, Akgul F, Yalcin F. Autonomic dysfunction and cardiac repolarization abnormalities in patients with migraine attacks. Med Sci Monit. 2007 13 : RA 47 49. (Pubitemid 46407605)
7. O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox AW. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia. 1999 19 : 223 231. (Pubitemid 29268495)
8. Dodick D, Lipton RB, Martin V, et al. The Triptan Cardiovascular Safety Expert Panel. Consensus statement: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache. 2004 44 : 414 425.
9. Luman W, Gray RS. Adverse reactions associated with sumatriptan. Lancet. 1993 341 : 1091 1092. (Pubitemid 23114428)
10. Vijayan N, Peacock JH. Spinal cord infarction during use of zolmitriptan: A case report. Headache. 2000 40 : 57 60. (Pubitemid 30091522)
11. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation. 2008 118 : 397 409.
12. Wasson S, Jayam VK. Coronary vasospasm and myocardial infarction induced by oral sumatriptan. Clin Neuropharmacol. 2004 27 : 198 200. (Pubitemid 39121735)
13. MacLean MR, Smth GC, Templeton AG. Adverse reactions associated with sumatriptan. Lancet. 1993 341 : 1092. Erratum in: 1164. (Pubitemid 23114428)
14. Ottervanger JP, Stricker BH. Cardiovascular adverse reactions to sumatriptan cause for concern? CNS Drugs. 1995 3 : 90 98.